(CLOX) Series Portfolios Trust - Ratings and Ratios
CLOs, AAA, ETF, Actively-Managed, Non-Diversified
Dividends
| Dividend Yield | 4.92% |
| Yield on Cost 5y | 5.77% |
| Yield CAGR 5y | 116.62% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 1.97% |
| Value at Risk 5%th | 3.09% |
| Relative Tail Risk | -4.86% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.23 |
| Alpha | 0.44 |
| CAGR/Max DD | 1.66 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.233 |
| Beta | 0.080 |
| Beta Downside | 0.251 |
| Drawdowns 3y | |
|---|---|
| Max DD | 4.13% |
| Mean DD | 0.09% |
| Median DD | 0.02% |
Description: CLOX Series Portfolios Trust October 29, 2025
The Series Portfolios Trust ETF (NYSE ARCA:CLOX) is an actively managed, non-diversified fund that allocates at least 80 % of its net assets (plus any investment-purpose borrowings) to collateralized loan obligations (CLOs) that are rated AAA or deemed equivalent at purchase.
Key metrics (as of the latest filing) show an expense ratio of 0.65 %, total assets under management of roughly $150 million, and a weighted-average maturity of about 5 years, reflecting the fund’s focus on short-duration, high-quality CLO tranches.
Performance drivers for CLOX are tightly linked to the broader leveraged-loan market: a tightening credit spread environment and stable or falling interest rates tend to boost CLO tranche valuations, while rising default rates in the corporate loan sector could erode returns. Recent data indicate U.S. leveraged-loan issuance has risen 12 % YoY, and AAA-rated CLO tranche default rates remain below 0.2 % over the past decade, supporting the fund’s credit quality premise.
If you want a data-rich, side-by-side comparison of CLOX against peers and macro scenarios, consider digging deeper on ValueRay for the latest analytics and scenario modeling tools.
What is the price of CLOX shares?
Over the past week, the price has changed by +0.14%, over one month by +0.51%, over three months by +1.31% and over the past year by +5.46%.
Is CLOX a buy, sell or hold?
What are the forecasts/targets for the CLOX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 29.2 | 14.3% |
CLOX Fundamental Data Overview December 05, 2025
Beta = 0.0
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 249.5m USD (249.5m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 249.5m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 249.5m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.31% (E(249.5m)/V(249.5m) * Re(6.31%) + (debt-free company))
Discount Rate = 6.31% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for CLOX ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle